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Title: Vastus lateralis motor unit firing rate is higher in females with patellofemoral 1 
pain 2 
Running head: Motor unit firing rate in patellofemoral pain 3 
ABSTRACT:  4 
Objective: To compare neural drive, determined from motor unit firing rate, to the vastus 5 
medialis and lateralis in females with and without patellofemoral pain. 6 
Design: Cross-sectional study. 7 
Setting: University research laboratory. 8 
Participants: Females (N=56) 19-35 years old, 36 with patellofemoral pain and 20 9 
controls. 10 
Interventions: Not applicable. 11 
Main Outcome Measure(s): Participants sustained an isometric knee extension 12 
contraction at 10% of their maximal voluntary effort for 70s. Motor units (N=414) were 13 
identified using high-density surface electromyography. Average firing rate was 14 
calculated between 5 and 35s after recruitment for each motor unit. Initial firing rate was 15 
the inverse of the first three motor unit inter-spike intervals. 16 
Results: In control participants, vastus medialis motor units discharged at higher rates 17 
than vastus lateralis (p=0.001). This was not observed in females with patellofemoral 18 
pain (p=0.78) due to a higher discharge rate of vastus lateralis compared to control 19 
participants (p=0.002). No between-group differences were observed for vastus 20 
medialis (p=0.93). Similar results were obtained for the initial motor unit firing rate. 21 
Conclusions: These findings suggest that females with patellofemoral pain have a 22 
higher neural drive to vastus lateralis but not vastus medialis, which may be a 23 
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contributor of the altered patellar kinematics observed in some studies. The different 24 
neural drive may be an adaptation to patellofemoral pain, possibly to compensate for 25 
decreased quadriceps force production, or a precursor of patellofemoral pain. 26 
 27 
KEYWORDS: Patellofemoral pain; Motor unit; EMG; quadriceps; neural drive 28 
ABBREVIATIONS LIST: PFP: Patellofemoral Pain; EMG: Electromyographic; VM: 29 
Vastus Medialis; VL: Vastus Lateralis; MU: Motor Unit; ES: Effect Size; CI: Confidence 30 
Interval.31 
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INTRODUCTION: 32 
Patellofemoral pain (PFP) is a musculoskeletal disorder characterized by anterior 33 
knee pain during activities such as stair climbing, squatting, and sitting for long periods 34 
1
. As lower knee extension strength is associated with PFP 2 and has been identified as 35 
a risk factor for PFP 3, altered neuromuscular function of the knee extensor muscles is 36 
considered to play a role in the development and maintenance of PFP 4. Specifically, as 37 
the medial and lateral components of the quadriceps apply different medio-lateral forces 38 
at the patella 5–8, their unbalanced activation may alter the pressure distribution across 39 
the patellofemoral joint 7 as well as patellar kinematics 8,9. 40 
A widely-investigated indicator of coordination between vasti muscle activation in 41 
PFP is the relative timing of activation of vastus medialis (VM) and lateralis (VL) 42 
muscles during movement 10–12. Yet, a systematic review has identified only a trend for 43 
delayed activation of the VM relative to VL, largely accounted for by large and 44 
unexplained variability across studies 13. Although timing measures are easy to obtain 45 
and provide valuable information, they only permit the identification of temporal 46 
differences in muscle activation.  47 
The force exerted by a muscle is known to depend on the number and discharge 48 
rate of its active motor units 14,15. Therefore, altered neural drive to VM and VL may be 49 
relevant for PFP. Previous studies have investigated surface electromyographic (EMG) 50 
amplitude to compare vasti muscle activation between participants with and without 51 
PFP 16–18. However, this provides only a crude indicator of the neural drive to a muscle, 52 
as surface EMG amplitude is influenced by factors such as: adipose tissue thickness, 53 
normalization, crosstalk, and motor unit action potential cancellation19, which may differ 54 
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between groups. In isometric tasks, the influence of these factors can be limited by 55 
estimating the neural drive from motor unit (MU) activity. Although motor unit activity 56 
has traditionally been assessed using intramuscular recordings, recent technological 57 
advances enable estimation of neural drive using non-invasive high-density surface 58 
electromyography 20. 59 
 The aim of this study was to compare the neural drive to the vastus medialis and 60 
lateralis in females with and without PFP during a submaximal, isometric task. On the 61 
basis of theories that propose a role for an unbalanced activation of the vasti muscles, 62 
we hypothesized that MU firing rate of VM would be lower in participants with PFP 63 
relative to asymptomatic controls, or VL would be higher, or both. 64 
 65 
METHODS: 66 
 Thirty-six females with PFP and 20 asymptomatic females (control participants) 67 
were recruited for the study from the community and from local physiotherapy clinics. To 68 
be included in the PFP group, participants had to be: female, 19-35 years old, with 69 
retro- or peri-patellar knee pain of intensity equal or greater than 3/10 for at least 1 70 
month aggravated by any of the following activities: sitting for long periods, stair 71 
ambulation, squatting, running, kneeling or jumping. They also needed to report pain or 72 
discomfort in at least one of the following tests: patellar palpation, patellar compression, 73 
resisted knee extension with the knee approximating full extension, or isometric knee 74 
extension while applying pressure proximally to the patella. These criteria were similar 75 
to those used in other studies 10,17,21; the screening was performed by a physiotherapist 76 
with more than 2 years of clinical experience in musculoskeletal assessment. Control 77 
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participants must not have had any knee pain in the last 12 months. Participants were 78 
excluded from either group if they had chronic neuromuscular disorders affecting the 79 
legs or previously had lower-limb surgery. All participants provided written informed 80 
consent before the experimental session. The study was approved by the institution's 81 
Clinical Research Ethics Board. 82 
 Body mass and height were measured, and age, time of onset of pain and 83 
average pain intensity in the previous week (11-point Numerical Rating Scale) were 84 
obtained by self-report. Physical activity (General Physical Activity Questionnaire, 85 
GPAQ 22) and functional limitation (Anterior Knee Pain scale 23) were evaluated using 86 
validated questionnaires. The test leg was the most painful knee if PFP was bilateral. 87 
For control participants, the leg was determined randomly before the testing session.  88 
 The protocol consisted of recording high-density surface EMG signals from both 89 
vasti during a submaximal, isometric task. The electrode grids were placed according to 90 
anatomical references24. The medial and lateral edges of VM and VL were identified 91 
using ultrasound imaginga and were marked on the skin. VM and VL innervation zones 92 
were located using a linear electrode array (16 silver bar electrodes, 10-mm 93 
interelectrode distanceb) and marked on the skin. Two electrode grids (semidisposable 94 
adhesive matrixb) were placed on the skin with the innervation zones aligned between 95 
the second and third column, and all the electrodes were placed over the muscle of 96 
interest. Each grid comprised 64 electrodes arranged in 5 columns and 13 rows with an 97 
electrode missing in one of the corners, 8 mm inter-electrode distance, and was held in 98 
place using bi-adhesive foam. In the VM, the longer dimension of the electrode grid 99 
(approximately 10 cm) spanned the distal-medial to the proximal-lateral region of the 100 
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muscle (fig. 1); for this reason, the grid placement provided EMG signals representative 101 
of different regions within each vastus muscle. Reference electrodes (2x3.5 cm; 102 
conductive hydrogelc) were placed on the patella and both sides of the knee. 103 
 Isometric knee extension torque was measured using an isokinetic 104 
dynamometerd. Participants were secured to the chair; the hip and knee angles were 85 105 
and 45 degrees of flexion, respectively. Resistance was applied approximately 2 cm 106 
proximal to the medial malleolus. Participants performed 3 maximal voluntary 107 
contractions (MVC) of knee extension with verbal encouragement, with a rest period of 108 
at least 60s between trials. The contraction intensity was increased to maximum over 109 
approximately 1-2s and was maintained for at least 3s before relaxation. The peak of 110 
the torque profile was extracted from each trial. The highest torque of the three values 111 
was considered the maximal knee extension strength, and normalized to body mass. 112 
The submaximal task consisted of a single 70s knee extension at 10% MVC. 113 
Participants were provided with real-time feedback of their knee extension torque and 114 
target. 115 
 High-density surface EMG signals were collected as monopolar recordings (128-116 
channel EMG-USBb). Signals were amplified 500-1000 times, filtered (band-pass 10-117 
750 Hz) and digitized at 2048 Hz using a 12-bit A/D converter. Knee extension torque 118 
was acquired simultaneously using the same amplifier. Butterworth filters (4th order; 10-119 
400 Hz for the EMG signals; low-pass 10 Hz for the torque) were applied to the signals 120 
before processing.  121 
Motor unit discharges were identified separately for VM and VL using a 122 
previously described method 25 that has been shown to be reliable between sessions 26 123 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
7 
 
and valid when compared to a gold-standard, intramuscular electromyography 27. An 124 
example of motor unit identification from surface EMG signals can be observed in figure 125 
1. Motor unit firing patterns were reviewed visually and firing rates >30 Hz or <3 Hz 126 
were manually excluded 26. Similar to a previous study28, the MU template was created 127 
by averaging epochs of 40ms around each MU discharge. The peak-to-peak amplitude 128 
was calculated for each of the 13x5 channels to identify the location of each MU, i.e. 129 
where it was represented with the highest amplitude. Motor unit recruitment was 130 
identified as the first of four consecutive discharges <500 ms apart. The initial MU firing 131 
rate was calculated as the inverse of those first three MU inter-spike intervals. The 132 
neural drive was quantified two ways: as the initial firing rate at recruitment, and the 133 
average firing rate, calculated as the average firing rate between 5s and 35s after motor 134 
unit recruitment. Additional parameters used to describe the population of MUs 135 
identified were: MU recruitment threshold, calculated as the torque value coincident with 136 
the first motor unit discharge (see above); MU location, calculated as the proximal-distal 137 
coordinate of the channel with largest peak value (along the longest dimension of the 138 
electrode grid, fig.2). 139 
 Statistical analyses were performed using SPSS v. 22e. After logarithmic 140 
transformation of average firing rate and initial firing rate, the assumptions of normally 141 
distributed data (Shapiro-Wilk’s test) and equal variances across groups (Levene’s test) 142 
were met. Demographic variables and knee extension strength were compared between 143 
groups using unpaired T-tests. Differences in MU firing rates between Groups (PFP, 144 
control) and Muscles (VM, VL) were tested using a two-way ANCOVA, separately for 145 
average firing rate and initial firing rate. To account for the effect of the MU recruitment 146 
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threshold on average firing rate and initial firing rate, recruitment threshold torque was 147 
included in the model as a covariate. Effect sizes (ES) were calculated using Cohen’s d, 148 
separately for each comparison. Two-way ANOVA was used to determine whether MU 149 
recruitment threshold torque or MU location differed between Groups or Muscles. Post-150 
hoc tests were corrected for multiple comparisons using Bonferroni corrections. 151 
Statistical significance was set at p<0.05. 152 
 153 
RESULTS: 154 
 When compared to control participants, participants with PFP were of similar 155 
age, height, weight and physical activity but had higher BMI and lower knee extension 156 
strength (Table 1). Twenty-six participants with PFP reported bilateral symptoms. After 157 
visual inspection, a total of 414 MUs were identified and included in the analyses. The 158 
number of identifiable MUs included for each participant ranged from 2-10 (mean 159 
MU/participant=4.8; total N=96) for the VM and 1-12 (mean 4.3; N=86) for the VL of 160 
controls, and 0-8 (mean 3.0; N=104) for the VM and 0-8 (mean 3.6; N=128) for the VL 161 
of participants with PFP. No MUs were identified from the VM of one participant with 162 
PFP and from the VL of 3 participants with PFP. 163 
 An interaction effect between Group and Muscle was observed in the MU 164 
average firing rate analysis (p<0.05; fig.3). A higher average firing rate was observed in 165 
the PFP group compared to controls for VL (8.8±1.7 Hz vs. 8.2±1.6 Hz, p=0.002, ES: 166 
0.34, 95% CI: [0.03 0.13]) but not for VM (8.9±2.0 Hz vs. 8.8±1.6 Hz, p=0.93, ES: 0.07, 167 
95% CI: [-0.05 0.06]). VM had a higher average firing rate than VL in controls (8.8±1.6 168 
Hz vs. 8.2±167 Hz, p=0.001, ES: 0.33, 95% CI: [0.04 0.15]), but no difference between 169 
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the two vasti was observed in females with PFP (8.9±2.0 Hz vs. 8.8±1.7 Hz, p=0.78, 170 
ES: 0.04, 95% CI: [-0.04 0.05]). Similarly, an interaction effect between Group and 171 
Muscle was observed in the MU initial firing rate analysis (p=0.001; fig.3). A higher initial 172 
firing rate was observed in the PFP group for VL (7.4±2.1 Hz vs. 6.4±1.7 Hz, p<0.001, 173 
ES: 0.49, 95% CI: [0.07 0.21]) but not for VM (7.1±2.0 Hz vs. 7.1±1.7 Hz, p=0.55, ES: 174 
0.03, 95% CI: [-0.09 0.05]). VM had a higher initial firing rate than VL in controls 175 
(7.1±1.7 Hz vs. 6.4±1.7 Hz, p=0.002, ES: 0.40, 95% CI: [0.05 0.20]), but no difference 176 
between the two vasti was observed in PFP (7.1±1.9 Hz vs. 7.4±2.1 Hz, p=0.17, ES: 177 
0.17, 95% CI: [-0.11 0.02]). Neither Muscle nor Group influenced the recruitment 178 
threshold torque (p>0.2) or MU position (p>0.15, fig.3). 179 
 180 
DISCUSSION: 181 
This study found differences in MU firing rate across individual heads of the 182 
quadriceps between females with and without PFP. In females without PFP, VM motor 183 
units discharged at higher rates than VL. This difference was not observed in those with 184 
PFP and was explained by a higher VL firing rate. We suggest that the greater neural 185 
drive to the VL may contribute to altered patellofemoral kinematics, which is proposed to 186 
be relevant for PFP. 187 
The evidence of higher neural drive to the VL in females with PFP implies a role 188 
of vasti muscle activation in the adaptation to, or in the development of, PFP. Our 189 
findings are strengthened by the fact that differences in neural drive cannot be attributed 190 
to the location of the motor unit within the muscle or its recruitment threshold, as neither 191 
differed between groups or muscles. Previous studies identified altered timing and 192 
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amplitude of surface EMG in PFP 10,12,16,18 and with experimental knee pain, 29–31. Our 193 
findings appear to concur with studies that reported earlier activation for VL rather than 194 
delayed activation of VM in reflex contractions 32 and when participants with PFP were 195 
asked to rise onto their toes 33. Overall, this study expanded this research, showing that 196 
the distribution of neural drive between VM and VL, measured as motor unit firing rate, 197 
differs between females with and without PFP. 198 
 Changes in muscle activation with pain and in musculoskeletal disorders are 199 
thought to be a purposeful adaptation to avoid pain in the short-term by altering joint 200 
kinematics 34. Previous studies on cadavers identified altered patellar kinematics 7 and 201 
pressure distribution within the patellofemoral joint 8 when the relative load of VM and 202 
VL was manipulated. In vivo studies showed that anesthetic block of the VM results in 203 
altered patellar kinematics 9. Studies using EMG timing and amplitude identified 204 
associations between VM/VL activation and patellar tilt 12,16.  205 
Considering the results of the aforementioned studies, a greater neural drive to 206 
the VL may result in a larger force produced by the lateral component of the quadriceps. 207 
However, caution must be used when inferring forces from muscle activation because 208 
muscle force depends on both neural activation and peripheral factors at the muscle 209 
level 35. As individuals with PFP may have smaller cross-sectional areas of the 210 
quadriceps muscles as a whole (see Giles and colleagues 36), the neural drive is likely 211 
an important contributor to the relative amount of force produced by VM and VL. 212 
However, other factors such as between-group differences in fiber type composition and 213 
structural parameters of the quadriceps could also play a role. 214 
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Higher discharge rates of VL and similar discharge rates for VM suggest that 215 
neural drive to the quadriceps as a whole is higher in PFP. This is in contrast with the 216 
clinical belief that the quadriceps muscle is inhibited in PFP, and it could inform the 217 
mechanisms that should be targeted in future intervention studies. Functionally, the 218 
greater neural drive to VL (or potentially vastus intermedius or rectus femoris – not 219 
measured in this study) could be an attempt to compensate for a decreased overall 220 
force production capability of the knee extensors, observed as smaller quadriceps 221 
cross-sectional area 36. Due to its architecture, VL mainly produces a force vector 222 
towards knee extension 5 and may be more efficient than VM to generate forces due to 223 
its greater physiological cross-section area 37. However, as the VL also applies a 224 
laterally-directed force vector on the patella 5–7, a selective increase of neural drive 225 
could potentially result in increased lateral forces applied to the patella. In line with this, 226 
some studies have reported an increased lateral patellar spin and translation 38,39 and 227 
higher joint reaction forces in the lateral patellofemoral compartment in PFP 40. The 228 
potential association between altered neural drive to the quadriceps and altered force 229 
production capabilities at the muscle could be observed in the cross-over effects of 230 
interventions targeting the two dysfunctions 42. Future studies should investigate the 231 
association between the force production capability of the quadriceps and the neural 232 
drive to the VL in PFP. 233 
The notion that unbalanced vasti activation may be due to greater neural drive to 234 
VL rather than VM inhibition may potentially have clinical implications. Traditionally, a 235 
putative imbalanced activation of VM and VL in PFP is treated by enhancing the 236 
activation of the medial component using techniques such as taping 43 and therapeutic 237 
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exercise intended to preferentially target the distal region of the VM 42. Less frequently, 238 
interventions such as taping 44,45 and botulinum injections 46 are aimed at reducing the 239 
activation or force produced by the VL. This study suggests that reducing the neural 240 
drive to the VL as opposed to increasing the neural drive to the VM may result in muscle 241 
activation patterns similar to individuals without PFP. Techniques that reduce/inhibit VL 242 
activation have a potential role in rehabilitation. This might be achieved in clinical 243 
practice using a variety of techniques, for instance, with taping techniques 44,45. Given 244 
the assumed link between muscle activity and resultant joint kinematics, our findings 245 
support the notion that reducing drive to VL may have positive clinical outcomes. Future 246 
longitudinal studies should also evaluate if reducing the neural drive to the VL improves 247 
patellofemoral kinematics and kinetics in PFP, resulting in less degeneration of the 248 
lateral patellar facet 41. The findings of this study may also be relevant for prevention. If 249 
differences in neural drive are present before the development of PFP, screening and 250 
early treatment may reduce the incidence of PFP; this however should be carefully 251 
evaluated in prospective studies. Overall, this study suggests that neural drive may be 252 
an important variable of interest in PFP, and further research into its clinical and 253 
biomechanical implications is warranted. 254 
 255 
LIMITATIONS:  256 
Due to the cross-sectional design of our study, whether the greater drive to the 257 
VL is an adaptation to, or precursor of, PFP cannot be determined. More research is 258 
needed to understand what drives the greater neural drive to the VL and if this motor 259 
control alteration can be observed in tasks other than isometric contractions. The 260 
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association between altered neural drive and differences in force production capabilities 261 
are not examined in the current study and should be assessed to make informed 262 
inferences on force production. It should be noted that changes in MU firing rate provide 263 
an accurate, but only partial, representation of changes in the neural drive. Changes in 264 
motor unit recruitment strategies, such as the number and population of active motor 265 
units, have been described with experimental knee pain 48 and are not accounted for by 266 
changes in firing rates. Lastly, only females with PFP were tested in this study to limit 267 
the confounding effect of sex-differences in anatomy, muscle strength and 268 
neuromuscular strategies. Thus, these findings are only generalizable to females with 269 
PFP; future studies should investigate whether similar findings are observed in males 270 
with PFP. 271 
 272 
CONCLUSIONS: 273 
 Motor unit firing rate of the vastus lateralis, but not medialis, during low-force, 274 
isometric contractions differs between females with and without PFP. Neuromuscular 275 
control of individual quadriceps heads could be considered a possible target for future 276 
interventions aimed to prevention and management of PFP. 277 
 278 
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FIGURE CAPTIONS: 290 
Fig.1: Experimental set-up and example of motor unit identification. Left: Placement of 291 
the electrode grids; the dashed line depicts the location of the innervation zones across 292 
both muscles. Middle: Double differential EMG signals from 10 channels of the VM of a 293 
control participant; three of the motor units automatically identified are highlighted with 294 
grey boxes (A, B, C). Right: the triggered-average surface EMG representation of each 295 
motor unit. 296 
 297 
Fig.2: Motor unit discharges and location. Left: firing rate of one motor unit from VM 298 
(black) and VL (gray) in one control participant and one with PFP. The torque signal is 299 
shown as a thick, light grey line; the recruitment threshold of the VM and VL MU is 300 
indicated as a black and a gray circle respectively. Right: examples of motor units 301 
located distally and proximally within the VL. Crosses on each surface EMG amplitude 302 
distribution identify the peak of the distribution; the Y coordinate of that channel was 303 
considered to be the proximal-distal location within the muscle. 304 
 305 
Fig.3: A) MU firing rate while holding 10% MVC. B) Initial MU firing rate. C) MU 306 
Recruitment threshold torque. D) MU position. Statistical significance for post-hoc 307 
comparisons is indicated. ** p<0.01. 308 
309 
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TABLE CAPTION: 310 
 311 
Table 1: Participant characteristics and knee extension strength. Pain intensity was 312 
subjectively rated indicating a number between 0 (no pain) and 10 (worst imaginable 313 
pain). Anterior knee pain scores of 100 indicate maximal function and no pain. KES: 314 
knee extension strength; nKES: normalized knee extension strength. 315 
316 
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Table 1: Participant characteristics and knee extension strength. Pain intensity was 
subjectively rated indicating a number between 0 (no pain) and 10 (worst imaginable 
pain). Anterior knee pain scores of 100 indicate maximal function and no pain. 
 CTRL PFP T-test 
AGE, years 25.6 (4.3) 26.7 (4.1) p=0.38 
HEIGHT, cm 167.7 (8.5) 166.4 (7.9) p=0.59 
BODY MASS, kg 58.2 (8.5) 62.3 (8.9) p=0.10 
BMI, kg/m2 20.6 (1.7) 22.5 (2.9) p=0.01* 
PHYSICAL ACTIVITY 22, 
 
METmin/week 
 
3153 (2034) 
 
4018 (2961) 
 
p=0.20 
PAIN ONSET, months 
(interquartile range) 
 
 
12-60 
 
PAIN INTENSITY, out of 10 0 (0) 4.1 (1.5)  
ANTERIOR KNEE PAIN 
 
SCORE 23, out of 100 
 
100 (0) 
 
74.3 (8.1) 
 
nKES, Nm/kg 2.3±0.4 1.9±0.5 p<0.01* 
KES, Nm 135.3±32.9 116.5±30.6 p<0.05* 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 
 
Figure 1
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
Figure 2 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
Figure 3 
 
 
